What companies are LGND's competitors?

Ligand Pharmaceuticals Incorporated (LGND)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does LGND compare to its peers?

The peer comparison table on this page shows Ligand Pharmaceuticals Incorporated (LGND) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does LGND operate in?

Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

LGND

Ligand Pharmaceuticals Incorporated

NASDAQ·Biotechnology · Healthcare

$311.73$3.43+1.11%

After hours·$311.85+0.04%

Market cap$6.21B·Market closed·Oct 27 4:00 PM EDT

Frequently Asked Questions About LGND

What companies are LGND's competitors?: Ligand Pharmaceuticals Incorporated (LGND)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LGND compare to its peers?: The peer comparison table on this page shows Ligand Pharmaceuticals Incorporated (LGND) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LGND operate in?: Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

LGND

Ligand Pharmaceuticals Incorporated

NASDAQ·Biotechnology · Healthcare

$311.73$3.43+1.11%

After hours·$311.85+0.04%

Market cap$6.21B·Market closed·Oct 27 4:00 PM EDT

Peers

Sort:


ABBVABBVAbbVie Inc.	AbbVie Inc.	$286.44	$506.2B
AMGNAMGNAmgen Inc.	Amgen Inc.	$447.95	$242.2B
PFEPFEPfizer Inc.	Pfizer Inc.	$29.80	$169.9B
BMYBMYBristol-Myers Squibb Company	Bristol-Myers Squibb Company	$61.55	$125.7B
GMABGMABGenmab A/S	Genmab A/S	$44.67	$27.5B
INCYINCYIncyte Corporation	Incyte Corporation	$116.60	$23.6B
EXELEXELExelixis, Inc.	Exelixis, Inc.	$65.35	$16.4B
BCRXBCRXBioCryst Pharmaceuticals, Inc.	BioCryst Pharmaceuticals, Inc.	$8.10	$2.1B
RIGLRIGLRigel Pharmaceuticals, Inc.	Rigel Pharmaceuticals, Inc.	$50.55	$944.3M

Frequently Asked Questions About LGND

What companies are LGND's competitors?: Ligand Pharmaceuticals Incorporated (LGND)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LGND compare to its peers?: The peer comparison table on this page shows Ligand Pharmaceuticals Incorporated (LGND) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LGND operate in?: Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.